FUZEON 90 mg/ml, powder and solvent for solution for injection 60 bottles of 2 ml
Active ingredients: Enfuvirtide
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injection60 bottles of 2 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FUZEON 90 mg/ml, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 60 flacon(s) en verre - 60 flacon(s) en verre de 2 ml avec 60 seringue(s) de 3 ml avec 60 seringue(s) de 1 ml avec 180 tampon(s) alcoolisé(s)
- Marketing authorisation holder
- ROCHE REGISTRATION (ALLEMAGNE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62723129CIP73622185CIP133400936221857Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ENFUVIRTIDEpoudre | 108 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.